Facebook Instagram Twitter RSS Feed Back to top

PhD. Topics

Centre of Social and Psychological Sciences SAS

Quality of life of cancer patients - investigation of manifestations of late toxicity due to different types of treatment at the level of cognitive functions
PhD. program
Social and work psychology
Name of the supervisor
Mgr. Jitka Gurňáková, PhD.
Receiving school
Comenius University in Bratislava
More than 85% of women with breast cancer live more than 5 years after the treatment, but they also suffer by the side effects of the disease itself and its treatment. Various side effects of oncological treatment (chemotherapy, radiotherapy and hormonal treatment) occur in up to 78% of people who have overcome the oncological disease. Less noticeable side effects of psychological cancer treatment include cancer-related cognitive impairment (CRCI), which has a significant impact on the individual quality of life and daily functioning of patients not only during treatment but also for several years after the treatment. Deterioration has been reported in several areas of cognitive function - in executive functions, verbal memory, speech skills, short-term memory or spatial orientation. The most common problems relate to memory and attention – for example word processing, task prioritization and decision-making
difficulties. These people often feel stressed, anxious, embarrassed, creating tension and frustration in the family, which has an immediate impact on their quality of life because it affects their emotional state and functioning (Yang, Hendrix, 2018). A study by a team of domestic authors (Chovanec et al., 2018), in turn, confirmed the adverse effects of oncological treatment on the quality of cognitive function in men with testicular cancer treated with both chemotherapy and radiation therapy. However, more detailed research in this area in men with testicular cancer is absent. The aim of this work will be quantitative and qualitative mapping of the current state and changes in quality of life due to cancer and its
treatment of patients with testicular cancer (or other types of cancer) at different stages of the disease who have been exposed to different types of treatment (assessment of changes in emotional survival, subjective and objective changes in the performance of cognitive functions, the impact of psychological predispositions and needs of the patient, sources of social support, adherence to treatment, subjective satisfaction with the quality of health care
provided and communication of health professionals during diagnosis and treatment of the patient, etc.).